Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
43 studies found for:    5-HT1A
Show Display Options
Rank Status Study
1 Completed Evaluation of [18F]MPPF as a Brain Tracer of Serotonin Receptor 5HT1a
Condition: Parkinson Disease
Intervention: Drug: [18F]MPPF
2 Withdrawn Imaging Serotonin 5HT1A Receptors in Patients With Major Depressive Disorder
Conditions: Major Depression;   Unipolar Depression;   Depression;   Anxiety Disorder
Intervention: Other: Antidepressant (SSRI)
3 Not yet recruiting Effects of TBS on 5-HT1A Receptor Binding
Condition: Treatment Resistant Depression
Interventions: Device: theta-burst stimulation using a MagPro X1000;   Device: sham stimulation using a MagPro X1000
4 Completed Study Evaluating Safety, Tolerability, Pharmacokinetics and 5 HT1A Receptor Occupancy
Condition: Alzheimer's Disease
Intervention: Drug: SRA-444
5 Completed Brain Chemical Receptor Effects in Patients With Panic Disorder and Post-Traumatic Stress Disorder
Conditions: Panic Disorder;   Posttraumatic Stress Disorder;   Major Depressive Disorder
6 Completed Hormonal Causes of Menstrual-Related Mood Disorders
Conditions: Mood Disorders;   Depression
7 Completed PET Imaging of Brain 5-HT(1A) Receptors Using [(11)C](-)-RWAY
Condition: Healthy Volunteers
Intervention: Drug: [11C] (-)-RWAY
8 Recruiting Investigation of the Serotoninergic System in Multiple System Atrophy: a Positron Emission Tomography (PET) Study
Condition: Multiple System Atrophy
Interventions: Radiation: PET (Positron Emission Tomography) Study;   Other: Brain MRI (magnetic resonance imaging);   Drug: Fluoxétine / Placebo
9 Completed PET Whole Body Distribution Studies Using [11C]CUMI
Conditions: Depression;   Major Depression;   Unipolar Depression;   Anxiety Disorder;   Anxiety Disorders
10 Recruiting PRX-00023 Therapy in Localization-Related Epilepsy
Conditions: Epilepsy;   Epilepsy, Temporal Lobe;   Partial Epilepsy
Intervention: Drug: PRX-00023
11 Completed Study Of Safety, Blood Levels, And Brain Receptor Occupancy Of GSK163090 Using PET Imaging In Healthy Males
Conditions: Healthy Subjects;   Depressive Disorder and Anxiety Disorders
Intervention: Drug: GSK163090
12 Completed The Effect of Neu-P11 on Symptoms in Patients With D-IBS
Condition: Diarrhea- Irritable Bowel Syndrome
Interventions: Drug: Neu-P11;   Drug: Placebo
13 Completed
Has Results
PET Trial to Assess the Receptor Occupancy of Brexpiprazole in Adult Subjects With Schizophrenia
Condition: Schizophrenia
Intervention: Drug: Brexpiprazole 1mg to 4mg
14 Completed (18F)FCWAY and the Blood-Brain Barrier
Condition: Drug Resistance
15 Completed Study Evaluating the Safety of Lecozotan SR in Healthy Young and Elderly Subjects
Condition: Alzheimer Disease
Intervention: Drug: Lecozotan SR
16 Completed FTIH Study With GSK958108
Condition: Premature Ejaculation
Intervention: Drug: GSK958108
17 Unknown  The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar Depressives
Conditions: Major Depressive Disorder;   Anxiety;   Comorbidity
Interventions: Drug: Vilazodone;   Drug: Citalopram
18 Completed Effects of Electroconvulsive Therapy (ECT) on Serotonin-1A Receptor Binding
Condition: Unipolar Depression
Intervention: Procedure: ECT
19 Recruiting Prediction of Clinical Response to SSRI Treatment in Bipolar Disorder Using Serotonin 1A Receptor PET Imaging
Condition: Bipolar Disorder
Intervention: Drug: Fluoxetine
20 Recruiting PET and MRI Brain Imaging of Bipolar Disorder
Conditions: Bipolar Disorder;   Bipolar Depression;   Unipolar Depression
Interventions: Drug: Lithium;   Drug: Lamotrigine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years